Researcher profile

Saroj Jayasinghe

Saroj Jayasinghe contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
3topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2021arXiv

A Thickness Sensitive Vessel Extraction Framework for Retinal and Conjunctival Vascular Tortuosity Analysis

Systemic diseases such as diabetes, hypertension, atherosclerosis are among the leading causes of annual human mortality rate. It is suggested that retinal and conjunctival vascular tortuosity is a potential biomarker for such systemic diseases. Most importantly, it is observed that the tortuosity depends on the thickness of these vessels. Therefore, selective calculation of tortuosity within specific vessel thicknesses is required depending on the disease being analysed. In this paper, we propose a thickness sensitive vessel extraction framework that is primarily applicable for studies related to retinal and conjunctival vascular tortuosity. The framework uses a Convolutional Neural Network based on the IterNet architecture to obtain probability maps of the entire vasculature. They are then processed by a multi-scale vessel enhancement technique that exploits both fine and coarse structural vascular details of these probability maps in order to extract vessels of specified thicknesses. We evaluated the proposed framework on four datasets including DRIVE and SBVPI, and obtained Matthew&#39;s Correlation Coefficient values greater than 0.71 for all the datasets. In addition, the proposed framework was utilized to determine the association of diabetes with retinal and conjunctival vascular tortuosity. We observed that retinal vascular tortuosity (Eccentricity based Tortuosity Index) of the diabetic group was significantly higher (p < .05) than that of the non-diabetic group and that conjunctival vascular tortuosity (Total Curvature normalized by Arc Length) of diabetic group was significantly lower (p < .05) than that of the non-diabetic group. These observations were in agreement with the literature, strengthening the suitability of the proposed framework.

preprint2020arXiv

Is the anti-filarial drug diethylcarbamazine useful to treat COVID-19?

The SARS-CoV-2 virus has resulted in a devastating pandemic of COVID-19. Exploring compounds that could offer a breakthrough in treatment is the need of the hour. Re-positioning cheap, freely available and safe drugs is a priority. The paper proposes evidence for the potential use of diethylcarbamazine (DEC) in the treatment of COVID-19. DEC has inhibitory effects on arachidonic acid metabolism to prostaglandins, little known anti-viral effects on animal retroviruses and demonstrated anti-inflammatory actions in animal models of lung inflammation indicating the need to explore this hypothesis further. We believe this is the first time DEC is being proposed to treat COVID-19.